GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » MedMen Enterprises Inc (OTCPK:MMNFQ) » Definitions » Debt-to-Equity

MedMen Enterprises (MedMen Enterprises) Debt-to-Equity : 3.10 (As of Mar. 2023)


View and export this data going back to 2018. Start your Free Trial

What is MedMen Enterprises Debt-to-Equity?

MedMen Enterprises's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2023 was $311.8 Mil. MedMen Enterprises's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2023 was $67.4 Mil. MedMen Enterprises's Total Stockholders Equity for the quarter that ended in Mar. 2023 was $122.4 Mil. MedMen Enterprises's debt to equity for the quarter that ended in Mar. 2023 was 3.10.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for MedMen Enterprises's Debt-to-Equity or its related term are showing as below:

MMNFQ's Debt-to-Equity is not ranked *
in the Drug Manufacturers industry.
Industry Median: 0.3
* Ranked among companies with meaningful Debt-to-Equity only.

MedMen Enterprises Debt-to-Equity Historical Data

The historical data trend for MedMen Enterprises's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MedMen Enterprises Debt-to-Equity Chart

MedMen Enterprises Annual Data
Trend Oct13 Oct14 Oct15 Oct16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22
Debt-to-Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.52 1.14 3.25 2.35 2.61

MedMen Enterprises Quarterly Data
Apr18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23
Debt-to-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.90 2.61 2.31 2.53 3.10

Competitive Comparison of MedMen Enterprises's Debt-to-Equity

For the Drug Manufacturers - Specialty & Generic subindustry, MedMen Enterprises's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


MedMen Enterprises's Debt-to-Equity Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, MedMen Enterprises's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where MedMen Enterprises's Debt-to-Equity falls into.



MedMen Enterprises Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

MedMen Enterprises's Debt to Equity Ratio for the fiscal year that ended in Jun. 2022 is calculated as

MedMen Enterprises's Debt to Equity Ratio for the quarter that ended in Mar. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


MedMen Enterprises  (OTCPK:MMNFQ) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.


Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.


MedMen Enterprises Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of MedMen Enterprises's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


MedMen Enterprises (MedMen Enterprises) Business Description

Traded in Other Exchanges
Address
10115 Jefferson Boulevard, Culver City, CA, USA, 90232
MedMen Enterprises Inc formerly known as Ladera Ventures Corp is the preeminent cannabis company with multiple assets and operations in California, Nevada, and New York, which combined account for nearly half of North America's addressable legal market. The company owns and operates licensed cannabis facilities in cultivation, manufacturing, and retail.